阿立哌唑与奥氮平治疗老年痴呆精神行为障碍对照研究

The Comparative Study of Aripiprazole Versus Olanzapine in the Treatment of Behavioral and Psychological Symptoms Associated with Senile Dementia

目的探讨阿立哌唑和奥氮平对老年痴呆精神行为症状(BPSD)的疗效和安全性。方法将58例老年痴呆伴BPSD患者随机分成2组,分别使用阿立哌唑和奥氮平治疗8周,采用痴呆病理行为评定量表(BEHAVE—AD)激越行为量表(CMAI)及治疗中出现的症状量表(TESS)评定疗效和不良反应。结果 2组治疗前后BEHAVE-AD和CMAI评分显著下降(P<0.01),2组之间治疗前后BEHAVE-AD总减分值差异无统计学意义(P>0.05),奥氮平组的嗜睡、体重增加、锥体外系反应较阿立哌唑显著(P<0.01)。结论阿立哌唑和奥氮平治疗老年痴呆BPSD的疗效相当,阿立哌唑安全性更高。

Objective To study the efficacy and safety of Aripiprazole and Olanzapine in the treatment of Behavioral and psychological symptoms of senile dementia（BPSD）.Methods 58 patients with BPSD were divided into two groups at random.One group of patients was treated by Aripiprazole for 8 weeks while another group of patients was treated by Olanzapine for same period.The effect and adverse effect were evaluated by adopting the behavioral pathology in Alzheimer＇s Disease Scale（BEHAVE-AD）,Cohen-Mansfield Agitation Inventory（CMAI）and Treatment Emergent Symptom Scale（TESS）.Results The BEHAVE-AD and CMAI scores of two groups decrease significantly after the treatment（P0.01）.The difference of BEHAVE-AD score between two groups is not statistically significant（P0.05）.The patients with symptoms of somnolence,getting weight,or extrapyramidal effect in Olanzapine group are more than those in Aripiprazole group（P0.01）.Conclusion The efficacy of Aripiprazole in the treatment of BPSD is the same as that of Olanzapine,but Aripiprazole is safer than Olanzapine.